Clifford Chance advised Ardian on the strategic acquisition by its investee company, The Dedalus Group, of DXC Technology’s (DXC: NYSE) healthcare software provider business for US$525…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
